• 1
    IARC. Cancer incidence in five continents, vol. 11. Lyon, France: IARC Scientific Publications, International Agency for Research on Cancer, World Health Organization, 2008.
  • 2
    IARC. Some drinking-water disinfectants and contaminants, including arsenic, vol. 84. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 2004.
  • 3
    NRC. Arsenic in drinking water. 2001 Update. Washington, DC: U.S. National Research Council, National Academy Press, 2001.
  • 4
    Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 2007;4:4629.
  • 5
    IARC. Solar and ultraviolet radiation, vol. 55. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 1992.
  • 6
    IARC. A review of human carcinogens: radiation, vol. 100D. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 2012.
  • 7
    Siemiatycki J, Richardson L, Straif K, et al. Listing occupational carcinogens. Environ Health Perspect 2004;112:144759.
  • 8
    Martinez VD, Vucic EA, Becker-Santos DD, et al. Arsenic exposure and the induction of human cancers. J Toxicol 2011;2011:113.
  • 9
    Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008;21:2844.
  • 10
    WHO. Arsenic in drinking-water. Background document for development of WHO guidelines for drinking-water quality. Geneva, Switzerland: World Health Organization, 2011.
  • 11
    EPA. Arsenic, inorganic (CASRN 7440-38-2): Carcinogenicity assessment for lifetime exposure. Washington, DC: Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, 1998.
  • 12
    IARC. A review of human carcinogens: arsenic, metals, fibres, and dusts, vol. 100C. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization, 2012.
  • 13
    ATSDR. Toxicological profile for arsenic. Atlanta, GA: Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Public Health Service, 2007.
  • 14
    WHO. Arsenic and arsenic compounds, 2nd edn. Geneva, Switzerland: Environmental Health Criteria 224, International Programme on Chemical Safety, World Health Organization, 2001.
  • 15
    Abernathy CO, Liu YP, Longfellow D, et al. Meeting on arsenic: health effects, mechanisms of actions, and research issues, Hunt Valley, Maryland, 22–24 September 1997. Environ Health Perspect 1999;107:5937.
  • 16
    Blair A, Freeman LB. Epidemiologic studies in agricultural populations: observations and future directions. J Agromed 2009;14:12531.
  • 17
    Leonardi G, Vahter M, Clemens F, et al. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case–control study. Environ Health Perspect 2012;120:7216.
  • 18
    ILO. International standard classification of occupations (ISCO), revised edition 1968. Geneva, Switzerland: International Labour Office, 1981.
  • 19
    Eurostat. Statistical classification of economic activities in the European community, NACE Rev. 1. Luxembourg: Office for Official Publications of the European Communities, 1996.
  • 20
    Siemiatycki J. Risk factors for cancer in the workplace. Boca Raton, FL: CRC Press, 1991.
  • 21
    Hough RL, Fletcher T, Leonardi GS, et al. Lifetime exposure to arsenic in residential drinking water in Central Europe. Int Arch Occup Environ Health 2010;83:47181.
  • 22
    Lindberg AL, Goessler W, Gurzau E, et al. Arsenic exposure in Hungary, Romania and Slovakia. J Environ Monit 2006;8:2038.
  • 23
    Hughes MF, Beck BD, Chen Y, et al. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci 2011;123:30532.
  • 24
    Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002;181/182:21117.
  • 25
    Bloom MS, Schisterman EF, Hediger ML. The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome. Fertil Steril 2007;88:70710.
  • 26
    Fleming LE, Bean JA, Rudolph M, et al. Mortality in a cohort of licensed pesticide applicators in Florida. Occup Environ Med 1999;56:1421.
  • 27
    Wesseling C, Antich D, Hogstedt C, et al. Geographical differences of cancer incidence in Costa Rica in relation to environmental and occupational pesticide exposure. Int J Epidemiol 1999;28:36574.
  • 28
    Suárez B, López-Abente G, Martínez C, et al. Occupation and skin cancer: the results of the HELIOS-I multicenter case–control study. BMC Public Health 2007;7:180.
  • 29
    Gallagher RP, Bajdik CD, Fincham S, et al. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 1996;5:41924.
  • 30
    Marehbian J, Colt JS, Baris D, et al. Occupation and keratinocyte cancer risk: a population-based case–control study. Cancer Causes Control 2007;18:895908.
  • 31
    Mitropoulos P, Norman R. Occupational nonsolar risk factors of squamous cell carcinoma of the skin: a population-based case-controlled study. Dermatol Online J 2005;11:5.
  • 32
    Smedley PL, Kinniburgh DG. A review of the source, behaviour and distribution of arsenic in natural waters. Appl Geochem 2002;17:51768.
  • 33
    Rossman T. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 2003;533:3765.
  • 34
    Tchounwou PB, Patlolla AK, Centeno JA. Invited reviews: carcinogenic and systemic health effects associated with arsenic exposure—a critical review. Toxicol Pathol 2003;31:57588.
  • 35
    Byrd DM, Roegner ML, Griffiths JC, et al. Carcinogenic risks of inorganic arsenic in perspective. Int Arch Occup Environ Health 1996;68:48494.
  • 36
    Burns FJ, Uddin AN, Wu F, et al. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ Health Perspect 2004;112:599603.
  • 37
    Rossman T. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 2004;198:394404.
  • 38
    Chen Y, Graziano JH, Parvez F, et al. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 2006;17:45967.
  • 39
    Melkonian S, Argos M, Pierce BL, et al. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am J Epidemiol 2010;173:18391.
  • 40
    Chen CJ, Chuang YC, Lin TM, et al. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985;45:58959.
  • 41
    Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 1998;27:5619.
  • 42
    Chen YC, Guo YL, Su HJ, et al. Arsenic methylation and skin cancer risk in Southwestern Taiwan. J Occup Environ Med 2003;45:2418.
  • 43
    Lindberg AL, Kumar R, Goessler W, et al. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 2007;115:10816.
  • 44
    Lindberg AL, Ekstrom EC, Nermell B, et al. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ Res 2008;106:11020.
  • 45
    Yu RC, Hsu KH, Chen CJ, et al. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 2000;9:125962.
  • 46
    Vahter M. Metals and women's health. Environ Res 2002;88:14555.
  • 47
    Vahter M, Gochfeld M, Casati B, et al. Implications of gender differences for human health risk assessment and toxicology. Environ Res 2007;104:7084.
  • 48
    McGuire V, Nelson LM, Koepsell TD, et al. Assessment of occupational exposures in community-based case–control studies. Annu Rev Public Health 1998;19:3553.
  • 49
    Teschke K, Olshan AF, Daniels JL, et al. Occupational exposure assessment in case–control studies: opportunities for improvement. Occup Environ Med 2002;59:57593.